TherapeuticsMD, Inc.
TXMD
Nasdaq
Manufacturing
Chemicals
$2.03
▼
$0.02
(-0.98%)
Mkt Cap: 23.50 M
Price
$2.03
Mkt Cap
23.50 M
Day Range
$2.02 — $2.06
52-Week Range
$0.84 — $2.95
Volume
4,911
Open $2.06
50D / 200D Avg
$2.27
10.41% below
50D / 200D Avg
$1.58
28.20% above
Price History
Financial Trends
No fundamental snapshot available yet.
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | 1.76 M | 1.30 M | 69.96 M | 86.95 M |
| Net Income | -569,000.0 | -2.18 M | -10.28 M | 112.00 M | -172.42 M |
| EPS (Diluted) | -0.05 | -0.19 | -0.98 | 11.96 | — |
| Gross Profit | — | — | 1.30 M | 68.57 M | 68.11 M |
| Operating Income | -4.39 M | -4.76 M | -8.52 M | 1.19 M | -139.77 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | — | — | — | — | 7.09 M |
| SG&A Expenses | — | 4.74 M | — | — | — |
| D&A | 384,000.0 | 509,000.0 | 922,000.0 | 1.19 M | 4.09 M |
| Interest Expense | 8,000.0 | 9,500.0 | 300,000.0 | 36.07 M | 32.92 M |
| Income Tax | -31,000.0 | -31,000.0 | -43,000.0 | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 37.66 M | 38.82 M | 43.31 M | 90.46 M | 169.47 M |
| Total Liabilities | 10.78 M | 11.45 M | 14.02 M | 55.32 M | 263.09 M |
| Shareholders' Equity | 26.88 M | 27.37 M | 29.29 M | 35.14 M | -93.62 M |
| Total Debt | — | — | — | 188.27 M | 188.27 M |
| Cash & Equivalents | — | 5.06 M | — | — | — |
| Current Assets | 14.45 M | 12.26 M | 11.80 M | 55.35 M | 119.47 M |
| Current Liabilities | 4.79 M | 5.17 M | 6.85 M | 46.84 M | 252.89 M |
{"event":"ticker_viewed","properties":{"ticker":"TXMD","listing_kind":"stock","pathname":"/stocks/txmd","exchange":"Nasdaq","country":"US"}}